In plain language
In a small randomized trial of 37 cardiac device extractions, a radiation protection cabin cut operator head dose about 68-fold and foot dose about 390-fold, without longer procedures or more complications. Thorax and back doses were similar.
At a glance
- Type of study
- Original research, Randomized trial
- Who was studied
- Electrophysiologists, Patients
- Size
- n = 37 patients (procedures)
- Summary based on
- the abstract
What it found
Operator head and foot doses were far lower with the radiation protection cabin than with the standard technique.
Key figures: 68 and 390 times less; P < 0.001
Thorax and back doses did not differ significantly between groups.
Key figures: P = 0.3 and P = 0.8
Procedure time, fluoroscopy time and complication rates were not significantly different with the cabin.
Authors conclude the cabin provides nearly full-body protection and removes the need for a lead apron.
Limits to keep in mind
Small single-procedure-type trial (37 patients) with operator dose measured by dosimeters rather than health outcomes; abstract only, so number of operators and country are not reported.
Related research summaries
- Obesity as a determinant of radiation burden in the cardiac catheterization laboratory (2026, Narrative review)
- Radiation Exposure, Training, and Safety in Cardiology (2024, Narrative review)
- Radiation-Induced Noncancer Risks in Interventional Cardiology: Optimisation of Procedures and Staff and Patient Dose Reduction (2013, Narrative review)
- Extended Protective Shield Under Table to Reduce Operator Radiation Dose in Percutaneous Coronary Procedures: The EXTRA-RAD Study (2019, Randomized trial)
- Radiation Exposure of Patients and Interventional Radiologists during Prostatic Artery Embolization: A Prospective Single-Operator Study (2017, Dosimetry measurement study)
How this summary was made
ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.
Prepared November 3, 2026.